BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 705049)

  • 1. Vaccination against canine bordetellosis using an aluminum hydroxide adjuvant vaccine.
    McCandlish IA; Thompson H; Wright NG
    Res Vet Sci; 1978 Jul; 25(1):51-7. PubMed ID: 705049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccination against Bordetella bronchiseptica infection in dogs using a heat-killed bacterial vaccine.
    McCandlish IA; Thompson H; Wright NG
    Res Vet Sci; 1978 Jul; 25(1):45-50. PubMed ID: 705048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccination against canine bordetellosis: protection from contact challenge.
    McCandlish IA; Thompson H; Wright NG
    Vet Rec; 1978 Jun; 102(22):479-83. PubMed ID: 685092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Canine parainfluenza-Bordetella bronchiseptica vaccine immunogenicity.
    Chladek DW; Williams JM; Gerber DL; Harris LL; Murdock FM
    Am J Vet Res; 1981 Feb; 42(2):266-70. PubMed ID: 6266289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Canine infectious tracheobronchitis: effects of an intranasal live canine parainfluenza-Bordetella bronchiseptica vaccine on viral shedding and clinical tracheobronchitis (kennel cough).
    Kontor EJ; Wegrzyn RJ; Goodnow RA
    Am J Vet Res; 1981 Oct; 42(10):1694-8. PubMed ID: 6275747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kennel cough: Vaccination against Bordetella bronchiseptica infection.
    McCandlish IA; Thompson H; Wright NG
    Vet Rec; 1976 Feb; 98(8):156-7. PubMed ID: 1266000
    [No Abstract]   [Full Text] [Related]  

  • 7. Studies on the efficacy of different adjuvants in live stock specific bacterial vaccines for turkeys against Bordetella infection and onset of antibody titers in respect to the age of the turkey poults.
    Glünder G; van der Ven H; Foulman A
    Pol J Vet Sci; 2004; 7(2):77-81. PubMed ID: 15230536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of vaccination on experimental infection with Bordetella bronchiseptica in dogs.
    Ellis JA; Haines DM; West KH; Burr JH; Dayton A; Townsend HG; Kanara EW; Konoby C; Crichlow A; Martin K; Headrick G
    J Am Vet Med Assoc; 2001 Feb; 218(3):367-75. PubMed ID: 11201562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intranasal immunization of dogs against Bordetella bronchiseptica-induced tracheobronchitis (kennel cough) with modified live-Bordetella bronchiseptica vaccine.
    Shade FJ; Goodnow RA
    Am J Vet Res; 1979 Sep; 40(9):1241-3. PubMed ID: 525927
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of the mucosal immune response in dogs vaccinated with either an intranasal avirulent live culture or a subcutaneous antigen extract vaccine of Bordetella bronchiseptica.
    Davis R; Jayappa H; Abdelmagid OY; Armstrong R; Sweeney D; Lehr C
    Vet Ther; 2007; 8(1):32-40. PubMed ID: 17447223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bordetella bronchiseptica pneumonia in a kidney-pancreas transplant patient after exposure to recently vaccinated dogs.
    Gisel JJ; Brumble LM; Johnson MM
    Transpl Infect Dis; 2010 Feb; 12(1):73-6. PubMed ID: 19874567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intranasal vaccination of dogs with liver avirulent Bordetella bronchiseptica: correlation of serum agglutination titer and the formation of secretory IgA with protection against experimentally induced infectious tracheobronchitis.
    Bey RF; Shade FJ; Goodnow RA; Johnson RC
    Am J Vet Res; 1981 Jul; 42(7):1130-2. PubMed ID: 7271029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Demonstration of 1-year duration of immunity for attenuated Bordetella bronchiseptica vaccines in dogs.
    Lehar C; Jayappa H; Erskine J; Brown A; Sweeney D; Wassmoen T
    Vet Ther; 2008; 9(4):257-62. PubMed ID: 19177330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental respiratory disease in dogs due to Bordetella bronchiseptica.
    Thompson H; McCandlish IA; Wright NG
    Res Vet Sci; 1976 Jan; 20(1):16-23. PubMed ID: 1257623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous analysis of the nasal shedding kinetics of field and vaccine strains of Bordetella bronchiseptica.
    Iemura R; Tsukatani R; Micallef MJ; Taneno A
    Vet Rec; 2009 Dec; 165(25):747-51. PubMed ID: 20023279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of commercial vaccines for protecting guinea pigs against Bordetella bronchiseptica pneumonia.
    Matherne CM; Steffen EK; Wagner JE
    Lab Anim Sci; 1987 Apr; 37(2):191-4. PubMed ID: 3599889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative efficacy of an injectable vaccine and an intranasal vaccine in stimulating Bordetella bronchiseptica-reactive antibody responses in seropositive dogs.
    Ellis JA; Krakowka GS; Dayton AD; Konoby C
    J Am Vet Med Assoc; 2002 Jan; 220(1):43-8. PubMed ID: 12680446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parenteral vaccination of young swine against Bordetella bronchiseptica.
    Farrington DO; Switzer WP
    Am J Vet Res; 1979 Oct; 40(10):1347-51. PubMed ID: 525851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity of killed Bordetella bronchiseptica vaccines in the mouse.
    Smith IM; Baskerville AJ; Brothwell E; Oliphant J
    Res Vet Sci; 1982 Mar; 32(2):248-52. PubMed ID: 7079606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Compatibility of a bivalent modified-live vaccine against Bordetella bronchiseptica and CPiV, and a trivalent modified-live vaccine against CPV, CDV and CAV-2.
    Jacobs AA; Bergman JG; Theelen RP; Jaspers R; Helps JM; Horspool LJ; Paul G
    Vet Rec; 2007 Jan; 160(2):41-5. PubMed ID: 17220520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.